Скачать клипы Ash23 ↓

ASH23: Iberdomide Maintenance in EMN26 Study Post Stem-Cell Transplant | Neils van de Donk, MD, PhD

ASH23: Iberdomide Maintenance in EMN26 Study Post Stem-Cell Transplant | Neils van de Donk, MD, PhD

Аш 23 - Сияй

Аш 23 - Сияй

Аш 23, DANU - Падали

Аш 23, DANU - Падали

Аш 23 - RAPSTAR (MUSIC VIDEO)

Аш 23 - RAPSTAR (MUSIC VIDEO)

ASH23: SeaLAND Study — Selinexor and Lenalidomide Combo for Newly Diagnosed Myeloma | Dr. Hang Quach

ASH23: SeaLAND Study — Selinexor and Lenalidomide Combo for Newly Diagnosed Myeloma | Dr. Hang Quach

ASH23: Iceland’s iStopMM Study on Free Light Chains and MGUS | Thorir Einarsson Long, MD, PhD

ASH23: Iceland’s iStopMM Study on Free Light Chains and MGUS | Thorir Einarsson Long, MD, PhD

ASH23: Perseus Trial: DARA + VRd vs. Vrd Alone in ASCT-Eligible Patients | Pieter Sonneveld, MD, PhD

ASH23: Perseus Trial: DARA + VRd vs. Vrd Alone in ASCT-Eligible Patients | Pieter Sonneveld, MD, PhD

ASH23: Katie Maurer, MD, PhD, on immune system features and CAR-T | Dana-Farber Cancer Institute

ASH23: Katie Maurer, MD, PhD, on immune system features and CAR-T | Dana-Farber Cancer Institute

ASH23: Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle...

ASH23: Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle...

Аш 23, DANU - Фиеста Фиеста

Аш 23, DANU - Фиеста Фиеста

ASH23: Andrew Hantel, MD, discusses clinical trial disparities | Dana-Farber Cancer Institute

ASH23: Andrew Hantel, MD, discusses clinical trial disparities | Dana-Farber Cancer Institute

ASH23: Corey Cutler, MD, MPH, on GVHD and stem cell transplant | Dana-Farber Cancer Institute

ASH23: Corey Cutler, MD, MPH, on GVHD and stem cell transplant | Dana-Farber Cancer Institute

ASH23: Corey Cutler, MD, MPH, on AGAVE-201 | Dana-Farber Cancer Institute

ASH23: Corey Cutler, MD, MPH, on AGAVE-201 | Dana-Farber Cancer Institute

ASH23: CARTITUDE-2 Trial on Ciltacabtagene Autoleucel in Multiple Myeloma | Jens Hillengass, MD, PhD

ASH23: CARTITUDE-2 Trial on Ciltacabtagene Autoleucel in Multiple Myeloma | Jens Hillengass, MD, PhD

ASH23: Jennifer Brown, MD, PhD, discusses ALPINE trial | Dana-Farber Cancer Institute

ASH23: Jennifer Brown, MD, PhD, discusses ALPINE trial | Dana-Farber Cancer Institute

ASH23: Abbv-383 BCMA x CD3 Bispecific Antibody for Relapsed/Refractory Myeloma | Ravi Vij, MD, MBA

ASH23: Abbv-383 BCMA x CD3 Bispecific Antibody for Relapsed/Refractory Myeloma | Ravi Vij, MD, MBA

ASH23: Reid Merryman, MD, on ct-DNA & diffuse large B-cell lymphoma | Dana-Farber Cancer Institute

ASH23: Reid Merryman, MD, on ct-DNA & diffuse large B-cell lymphoma | Dana-Farber Cancer Institute

ASH23: STEM Trial Study on Cevostamab Consolidation After BCMA CAR T-Cell Therapy | Adam Cohen, MD

ASH23: STEM Trial Study on Cevostamab Consolidation After BCMA CAR T-Cell Therapy | Adam Cohen, MD

ASH23: Shai Shimony, MD, molecular ontogeny in AML | Dana-Farber Cancer Institute

ASH23: Shai Shimony, MD, molecular ontogeny in AML | Dana-Farber Cancer Institute

Скачать клипы Ash23 бесплатно и без регистрации